who shouldn't take glp 1 drugs GLP-1 Medications for Weight Loss: How to Get Started | News Beyond the scale: How GLP-1

Extra caution is appropriate in patients with active cancer, recent cancer, unexplained masses, unexplained weight loss, pregnancy, breastfeeding, known allergy to peptide products, active infection, immune compromise, significant liver or kidney disease, active inflammatory or autoimmune disease flares, unusual clotting history, uncontrolled cardiovascular disease, use of chemotherapy or immune-modifying biologic therapy, and competitive athletes subject to anti-doping rules

Researchers sourcing it should understand the quality considerations involved

PPP, pentose-phosphate pathway

& Butcher, S

For example, metabolomics analysis of the liver metabolic profile of L-leucine treated tilapia during Streptococcus iniae infection reveals that serine is one of the two key metabolites